Order Article Reprints

Vaso CO, Bila NM, Pandolfi F, De Vita D, Bortolami M, Bonatti JLC, De Moraes Silva RA, Gonçalves LNC, Tudino V, Costi R, et al. Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures. Pharmaceutics. 2022; 14(5):1043. https://doi.org/10.3390/pharmaceutics14051043

Vaso, Carolina Orlando, Níura Madalena Bila, Fabiana Pandolfi, Daniela De Vita, Martina Bortolami, Jean Lucas Carvalho Bonatti, Rosângela Aparecida De Moraes Silva, Larissa Naiara Carvalho Gonçalves, Valeria Tudino, Roberta Costi, and et al. 2022. "Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures" Pharmaceutics 14, no. 5: 1043. https://doi.org/10.3390/pharmaceutics14051043

Vaso, C. O., Bila, N. M., Pandolfi, F., De Vita, D., Bortolami, M., Bonatti, J. L. C., De Moraes Silva, R. A., Gonçalves, L. N. C., Tudino, V., Costi, R., Di Santo, R., Mendes-Giannini, M. J. S., Costa-Orlandi, C. B., Scipione, L., & Fusco-Almeida, A. M. (2022). Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures. Pharmaceutics, 14(5), 1043. https://doi.org/10.3390/pharmaceutics14051043